WSLCB Interpretive Statement On Cannabinoid Additives

WASHINGTON:  Consistent with RCW 34.05.230, WSLCB has published an interpretive statement to clarify WAC 314-55-109 concerning cannabinoid additives.

One of the key findings of the 2019 Hillard Heintz report was that WSLCB licensees expressed concerns about inconsistent interpretation of law and regulation applying to their businesses.

Interpretive statements do not have the force and effect of law. They are explanatory documents intended to convey the Washington State Liquor and Cannabis Board’s interpretation of law and regulation as it exists at the time the statement is issued. Current interpretive statements are advisory only.

WLSCB Interpretive Statement #IS21-01 was filed with the Washington State Code Reviser on January 26, 2021 as WSR 21-04-030. The interpretive statement is intended to clarify and confirm current rule, WAC 314-55-109, concerning cannabinoid additives – requirements, restrictions, and quality assurance testing, including the ways that cannabidiol (CBD) product obtained from a source not licensed under chapter 314-55 WAC may be sold in licensed retail locations.

Additional information can be found on the WSLCB Interpretive Statements webpage.

OLCC Commission Bans Some Additives from Cannabis Vaping Products

Additives linked to potential harm to cannabis consumers

More transparent ingredient disclosure required going forward

OREGON:  At its regular monthly meeting on December 17, 2020, the Oregon Liquor Control Commission banned two ingredients immediately from further use in cannabis vaping products — squalene and squalane. In addition, the Commission approved rules designed to provide better protection for cannabis consumers by requiring recreational marijuana licensees provide more transparent disclosure of, screening for, and labeling of inhalable cannabinoid products that use non-cannabis additives. The Commission also ratified five stipulated settlements.

The action taken against squalene and squalane comes in the wake of an OLCC investigation (see December 11, 2020 press release) that uncovered the use of those ingredients in cannabinoid vaping products sold in Oregon. The OLCC found that squalene and squalane were not disclosed as ingredients and were included on product labels as “natural flavors.” Studies, including one commissioned by the OLCC, have shown that squalene and squalane can produce harmful chemicals when exposed to heat and inhaled, posing potential harm to consumer health.

If the OLCC discovers any remaining products in the marketplace that contain squalene or squalane, those products will be subject to an immediate recall, a provision included in the new rules. Squalene and squalane join Vitamin E acetate on OLCC’s list of banned adulterants; as a result of the Commission’s actions, propylene glycol (PG) and triglycerides, like MCT oil, will be added to the list effective April 1, 2021.

The Commission began examining the impact of non-cannabis additives in the wake of the e-cigarette use-associated lung injury (EVALI) health crisis in mid-2019. During 2020, the OLCC held a series of discussions with cannabis industry stakeholders, public health officials and OLCC cannabis licensees to contemplate an approach for identifying and screening out non-cannabis ingredients added to cannabis products that pose a potential danger to human health. A framework for applying those standards was used to create the rules.

The approved rules will help the Commission protect health and safety by compelling greater ingredient disclosure, and to address both the acute and chronic health effects of additive ingredients when heated and inhaled by specifying the standards for non-cannabis additives being used in inhalable cannabinoid products. Because of the disclosure requirements, licensees and consumers will have greater assurance that any additives used in cannabis vape products were manufactured with the intent that they would be inhaled.

The rules take effect December 22, 2020, and the OLCC on that date will immediately begin accepting label applications under new rules for inhalable cannabinoid products. The Cannabis Tracking System (CTS) will be updated by that time to include a category for designating inhalable cannabinoid products.

Any inhalable cannabinoid products made on or after April 1, 2021, will be subject to the new rules, including no use of PG or MCT and full disclosure of additive ingredients on the item’s label. By April 1, all inhalable cannabinoid products (regardless of manufacture date) must also be tracked in CTS with disclosure of the additive mix used in the cannabinoid product.

From April 1 to July 1, 2021, OLCC recreational marijuana licensees are allowed to “sell down” any inhalable cannabinoid products made before April 1, 2021. Beginning July 1, 2021, all inhalable cannabinoid products in the marketplace must comply with the new rules and standards, and anything that does not comply, regardless of manufacture date, must be destroyed.

The Commission also ratified the following violation fines and suspensions based on stipulated settlements (detailed information on specific cases can be found here on the OLCC website):

SHADOWBOX FARMS (#1467A) will serve an 32-day recreational marijuana producer license suspension OR pay a fine of $5,280 for one violation.

Licensee is: Rogue Valley Group, LLC; Tim Winner, Manager; Artemis Group, LLC, Member; Joseph Bundy, Member; Megan Bundy, Member; Bryan Bundy, Member.

FLOWERSMITH will serve a 14-day recreational marijuana producer license suspension OR pay a fine of $2,310 for two violations.

Licensees are: Flowersmith, LLC; Samuel Felton, Member; Gavin Henner, Member

BLACK MARKET DISTRIBUTION will serve a 69-day recreational marijuana wholesaler license suspension OR pay a fine of $11,385 for three violations.

Licensees are: Black Market Distribution, LLC; Aaron Mitchell, Member; Rosa Cazares, Manager.

COPPERHEAD ORGANIC FARMS will surrender its license at the earlier of the date of transfer of ownership of the business or February 19, 2021 for four violations.

Licensees are: CH Organics, LLC; Corey Tarr, Member; Debra Davis Estate, Member.

OLCC Identifies Potential Consumer Harm In Some Cannabis Vape Products

Voluntary recall started because non-cannabis additives had undisclosed ingredients

Investigation continues to determine impact across Oregon’s legal cannabis industry

OREGON:  As part of an on-going consumer product safety investigation, the Oregon Liquor Control Commission has identified that marijuana products sold in Oregon’s recreational marijuana market during the last two years contained additives, squalene and squalane, that have been linked to safety concerns similar to Vitamin E Acetate when vaped and inhaled. The OLCC is working to trace products and when necessary remove them from sale. OLCC will be considering immediate action at its December 2020 Commission meeting to prohibit future use of squalene and squalane, institute a mandatory recall of affected products, and create a more stringent and transparent review process of cannabis vaping products going forward.

Recreational retail shops won’t be open until October.

The products under investigation by OLCC contained Viscosity, a non-cannabis diluent manufactured and sold by a third-party (non-OLCC marijuana licensee). Some of the product remains on the market, and the OLCC is working to trace and remove it.

Bulk Naturals LLC., dba True Terpenes, sold Viscosity that solely contained squalene, squalane, and an unidentified olive extract to OLCC recreational marijuana licensees between at least January 2018 and November 2019. Squalene is a “botanically-derived terpene” that can be derived from olives; squalane is the hydrogenated version of squalene. Following OLCC’s confirmation of the presence of squalane in Viscosity via independent laboratory analysis by ChemHistory and SC Labs, True Terpenes has complied with all of OLCC’s requests for information. Viscosity has since been reformulated, and according to True Terpenes, none of their products have contained squalene or squalane since November 2019.

As a result of its investigation the OLCC has identified recreational marijuana licensees that potentially used Viscosity in their products.  Because of their purchase of Viscosity, OLCC has requested additional information from several licensees about products they have manufactured.

One licensee – Oregrown, a vertically integrated cannabis company based in Bend – swiftly provided the requested documentation. Oregrown was the first licensee to confirm its use of the Viscosity formula under investigation, and since then has been working with the OLCC to voluntarily recall the limited amount of its remaining product containing Viscosity. OLCC has provided Oregrown with the information regarding affected items still on the market and their current location.

Oregrown utilized Viscosity in making Oregrown PAX Era D9 Elite style vaping products manufactured on or prior to August 31, 2019. Although Oregrown has reformulated its PAX product to no longer include Viscosity, the previously manufactured items containing the prior Viscosity formula remain in the market. The most recent sales from Oregrown PAX Era D9 Elite products containing this prior Viscosity formula were in October 2020.

In all, between April 2018 and October 2020, 268 OLCC licensed recreational marijuana retailers sold this item.

Consumers can verify the date of manufacture and whether an item they have purchased is subject to this recall. Any Oregrown PAX Era D9 Elite item with the label identification of “2520” and made before August 31, 2019 should be destroyed by the consumer or returned to the retailer where the item was purchased.

The OLCC has found that Oregrown was NOT aware of the contents of Viscosity and didn’t know that it contained potentially harmful ingredients. At the time that Oregrown used Viscosity, the manufacturer, True Terpenes, did not publicly disclose any of Viscosity’s ingredients due to claims of trade secret protections. Oregrown has provided all information that OLCC has requested, and its products complied with OLCC’s labeling rules at the time. OLCC expects that other licensees will act just as swiftly in order to ensure consumer safety by assisting the Commission in identifying and removing these potentially harmful products from the market.

The OLCC has been concerned about the presence of undisclosed ingredients in cannabis vaping products, and during the last year has been examining the use of non-cannabis additives. As part of this review OLCC has gathered evidence that certain additives pose potential danger to consumers.

At the same time the OLCC has suspected that these unhealthy additives had already been introduced into Oregon’s recreational marijuana system without the knowledge of licensees. The OLCC has been investigating the presence of unknown additives in cannabis vape products, which led to OLCC’s independent discovery of squalene and squalane tainted products.

OLCC recently commissioned a study that determined that when exposed to heat, squalene and squalane produce harmful chemicals. It has also been documented that inhaling squalene has been associated with exogenous lipoid pneumonia. Initial evidence about these additives also suggests a potential for consumer harm similar to that already proven about Vitamin E Acetate.

In light of these recent findings, OLCC staff will be proposing two actions at OLCC’s December 17, 2020, Commission meeting. One will be an action that would declare squalene and squalane adulterants; if approved by the Commission, any items in Oregon’s regulated market to which squalene or squalane have been added would be subject to a mandatory public health and safety recall. The second proposed action will be rules regarding cannabis vaping products that have been under development since July 2020; these rules would establish greater transparency and accountability regarding non-cannabis ingredients, like Viscosity, that are used in cannabis vaping products sold in the OLCC system.

OLCC is continuing its investigation into licensees that purchased Viscosity during the relevant time frame in order to confirm whether it was used in any other vaping products that were sold to consumers. If it is determined that other licensees used the prior formulation of Viscosity without proper disclosure on the item’s label, or have withheld information from the OLCC regarding the use of Viscosity, OLCC will pursue compliance action against those licensees as necessary. Additional health and safety recalls may be issued as more information is discovered.

WSLCB Virtual Listen and Learn Forum Session #2: Rules Regarding Marijuana Vapor Products

WASHINGTON:  The Washington State Liquor and Cannabis Board (WSLCB) is hosting two Listen and Learn forums to consider establishing new and amending existing sections of rule concerning marijuana definitions and marijuana vapor products. This is the second of two planned sessions. The full text of the draft conceptual rules are provided here.

For this session, we are discussing only draft conceptual rule sections 314-55-550 to implement House Bill 2826 pertaining to marijuana vapor products, and the Marijuana Vapor Product Disclosure Form. The Disclosure Form is provided here.

Please join us virtually on Tuesday, September 29, 2020, from 2:00 p.m. until 4:00 p.m. via WebEx.

**Attendees wishing to provide feedback are encouraged to participate early in the meeting, as the meeting may end early dependent on level of participation.**

Background
On March 25, 2020, HB 2826 passed the legislature in response to concerns related to marijuana vapor product and vapor related lung illnesses. The bill contained an emergency clause, and in its intent section, found that “recent reports of lung illnesses associated with vapor products” demanded “serious attention by the state in the interest of protecting public health and preventing youth access.

HB 2826 provides that the Board may adopt rules prohibiting any type of marijuana vapor product device, or prohibit the use of any type of additive, solvent, ingredient, or compound in the production and processing of marijuana products, including marijuana vapor products. However, before adopting either of these types of rules, the Board must have determined, following a consultation with the Department of Health (DOH), or any other authority the Board deems appropriate, the device, additive, solvent, ingredient, or compound may pose a risk to public health or youth access.

HB 2826 authorizes the Board to require marijuana processors to submit, under oath, to the Department of Health, a complete list of all constituent substances and the amount and sources of all constituent substances in each marijuana vapor product. HB 2826 also provides that Board may adopt rules prohibiting the use of a characterizing flavor in marijuana vapor products.

Rules are needed to implement the provisions of HB 2826, and to establish definitions for terms including, but not limited to “characterizing flavor,” botanical terpenes,” and others.

The Pre-proposal Statement of Inquiry filed by the Liquor and Cannabis Board may be found here.

Meeting Details
An agenda is attached. Please come prepared to offer feedback and suggestions regarding this rule section.

If you wish to participate virtually, we’d like to offer the following reminders:

  • Virtual participation will be structured to allow one speaker at a time through a hand-raising feature on WebEx.
  • If you experience difficulty with audio or visual elements of virtual participation, please be patient.

Please remember that we are still in the developmental phase of rulemaking, and there are not yet any proposed or final rules amendments. To help you prepare for this listen/learn/contribute forum, please review the guidance document prepared for this and future forums.

Questions? Contact Casey Schaufler at casey.schaufler@lcb.wa.gov

To join the WebEx meeting online:
https://watech.webex.com/watech/j.php?MTID=m208eaad1ec16f31cfccdf6970963e1cb


To join the WebEx meeting via audio conference only:
Dial: (415) 655-0001
Access Code: 372 115 47

WASHINGTON: Virtual Listen And Learn Forum Session #1: Rules Regarding Marijuana Definitions And Vapor Products

WASHINGTON:  The Washington State Liquor and Cannabis Board (WSLCB) is hosting two Listen and Learn forums to consider establishing new and amending existing sections of rule concerning marijuana definitions and marijuana vapor products. This is the first of two planned sessions. The full text of the draft conceptual rules are provided here.

For this session, we are discussing only draft conceptual rule sections 314-55-010(4) and (40) to implement House Bill 2826 pertaining to marijuana vapor products.

Please join us virtually on Tuesday, September 1, 2020, from 2:00 p.m. until 3:45 p.m. via WebEx.

Background
On March 25, 2020, HB 2826 passed the legislature in response to concerns related to marijuana vapor product and vapor related lung illnesses. The bill contained an emergency clause, and in its intent section, found that “recent reports of lung illnesses associated with vapor products” demanded “serious attention by the state in the interest of protecting public health and preventing youth access.

HB 2826 provides that the Board may adopt rules prohibiting any type of marijuana vapor product device, or prohibit the use of any type of additive, solvent, ingredient, or compound in the production and processing of marijuana products, including marijuana vapor products. However, before adopting either of these types of rules, the Board must have determined, following a consultation with the Department of Health (DOH), or any other authority the Board deems appropriate, the device, additive, solvent, ingredient, or compound may pose a risk to public health or youth access.

HB 2826 authorizes the Board to require marijuana processors to submit, under oath, to the Department of Health, a complete list of all constituent substances and the amount and sources of all constituent substances in each marijuana vapor product. HB 2826 also provides that Board may adopt rules prohibiting the use of a characterizing flavor in marijuana vapor products.

Rules are needed to implement the provisions of HB 2826, and to establish definitions for terms including, but not limited to “characterizing flavor,” botanical terpenes,” and others.

The Pre-proposal Statement of Inquiry filed by the Liquor and Cannabis Board may be found here.

Meeting Details
An agenda is attached. Please come prepared to offer feedback and suggestions regarding this rule section.

If you wish to participate virtually, we’d like to offer the following reminders:

  • Virtual participation will be structured to allow one speaker at a time through a hand-raising feature on WebEx.
  • If you experience difficulty with audio or visual elements of virtual participation, please be patient.

Please remember that we are still in the developmental phase of rulemaking, and there are not yet any proposed or final rules amendments. To help you prepare for this listen/learn/contribute forum, please review the guidance document prepared for this and future forums.

Questions? Contact Casey Schaufler at casey.schaufler@lcb.wa.gov

To join the WebEx meeting online:
https://watech.webex.com/watech/j.php?MTID=mee35a3ea86f3824ff52650252c672ee9

To join the WebEx meeting via audio conference only:

  • Toll Free: 1-855-929-3239
  • Toll: 415-655-0001
  • Access Code: 133 951 6990

Massachusetts Cannabis Control Commission Issues Second Amended Quarantine Order for Vaporizer Products

Cannabis Control Commission Issues Second Amended Quarantine Order for Vaporizer Products

Following the agency’s three-phased testing and public comment period, licensees may retest and release, or destroy quarantined products subject to order requirements

MASSACHUSETTS:The Cannabis Control Commission (Commission) has issued a Second Amended Quarantine Order Applying to Vaporizer Products following three phases of testing and a public comment period which examined conditions that could allow for the retest and sale of vaporizer products that were previously quarantined since December. Under the second amended order, licensees may retest and release—or destroy—certain products with enhanced warning labels, depending on testing and remediation outcomes, and compliance with Commission regulations and policies. The order emphasizes that measured, transparent testing mitigates, but does not eliminate, all public health risks posed by quarantined vaporizer products.

This latest action modifies previous Commission quarantine orders issued in November and December 2019 and related investigative findings from the US Centers for Disease Control and Prevention (CDC) that identified vitamin E acetate (VEA) as a chemical of concern among people with e-cigarette, or vaping, product-use associated lung injury (EVALI). On December 12, 2019, the Commission issued the First Amended Quarantine Order authorizing licensees to sell newly manufactured vaporizer products, but requiring that more than 600,000 vaporizer products manufactured before December 12, 2019 remain subject to quarantine.

“Since the Commonwealth declared a vaping public health emergency last fall, the Commission has dedicated significant energy and resources to investigating the additives, hardware, and storage practices that licensees use to produce and sell cannabis vaporizer products,” Commission Executive Director Shawn Collins said. “Fortunately, repeat tests of licensed product samples did not return any detectable levels of VEA; unfortunately, they did establish that heavy metal contamination may increase in vaping products over time.

“This new order seeks to strike a balance between those products that can be retested or remediated safely for sale or repurposing with proper warning to patients and consumers, and those that cannot. As the nation continues to learn more about the broader health implications of vaping in all forms, I urge patients and consumers to understand the risks when they choose to consume any cannabis vaporizer product.”

The Commission’s regulations require all marijuana products to undergo contaminant testing, including testing for heavy metals, by an Independent Testing Laboratory accredited to the International Organization for Standardization 17025 (ISO/IEC 17025: 2017) and in accordance with the Commission’s Protocol for Sampling and Analysis of Finished Medical Marijuana Products and Marijuana-infused Products.

Under the second amended order, previously quarantined products may be:

  • Disposed. Licensees may voluntarily dispose of previously quarantined vaping products at any time, subject to Commission disposal regulations.
    • Production batches that previously failed both Commission-initiated tests for heavy metals shall be deemed unable to be remediated and face mandatory disposal, if, after two attempts at remediation, the product does not pass testing for heavy metals. Respondents may dispose of such products voluntarily or upon receiving an order of destruction from the Commission.
  • Retested and Released. Previously quarantined products may be made available for sale if they are first retested and deemed compliant with the Commission’s regulations and policies, subject to conditions specified in the order.
  • Reclaimed. Previously quarantined products may also be repurposed into other products using the reclaimed marijuana oil, although any new product manufactured with that oil must undergo testing and include a statement indicating to the patient or consumer that the product was manufactured with previously quarantined material.

If, after two attempts at remediation, retested or reclaimed products do not pass testing for heavy metals, they will be considered unable to be remediated and must be disposed. Vaporizer products with original testing dates in excess of one year are considered expired and may not be dispensed, sold, transferred or otherwise conveyed until another screen for all contaminants, excluding pesticides, is conducted. In accordance with Commission regulations, licensees must notify the agency of any vaporizer product test result exceeding acceptable levels for heavy metals and describe the method for remediation or disposal.

The second amended order also specifies labeling requirements for all vaporizer products sold by licensees in the Commonwealth, including, but not limited to those products that are retested or reclaimed in accordance with the second amended order:

  • Labels on previously vaporized products that pass retesting and are made available for sale must disclose, “This product was previously quarantined. Passed retesting for heavy metals and Vitamin E Acetate. Store at room temperature.”
  • Labels on previously vaporized products that have their marijuana concentrate reclaimed for other marijuana products must disclose, “This product was produced using previously quarantined concentrate. Passed retesting for heavy metals and Vitamin E Acetate. Store at room temperature.”

Retailers and Medical Marijuana Treatment Centers (MTCs) must include in the sale of vaporizer products a disclosure that the patient or consumer may request to inspect a copy of the product’s associated testing results. Disposable and reusable vaporizer pens also must include a product insert that identifies the materials used in the device’s atomizer coil. Any quarantined vaping product that is resold also must include the item’s original packaging date.

The Commission has mandated that Marijuana Product Manufacturers retain certain records pertaining to marijuana vaporizer ingredients, additives, devices, component parts, or other materials purchased from any manufacturer or supplier; the name and business address of the manufacturer of any cartridge, battery, atomizer coil (and its materials used), hardware, or other component of marijuana vaporizer products; and the Certificate of Analysis for each thickening agent, thinning agent, and terpene infused or incorporated into a marijuana vaporizer device during production.

Starting last December, the Commission conducted three phases of testing into vaporizer products manufactured and sold by licensees. Results are available on the Commission’s website under MassCannabisControl.Com/Documents.

The Commission’s first two testing phases investigated VEA and heavy metal (lead) levels in samples of vaporizer products collected from geographically diverse locations. Phase III involved confirmatory tests of certain products that failed for heavy metal concentrations above the acceptable limits for inhalation (500 ppb), and found varying results, to suggest that heavy metal contamination may increase over time. Testing limitations identified during the investigation included limited sampling scope, product batch homogeneity, inconsistent extraction procedures for testing finished cartridge samples, and lack of known sources of metal contamination. VEA has not been detected in any Commission-initiated testing.

After testing methods precluded reliable results, the Commission determined further investigation and collaboration was necessary before issuing a second amended order pertaining to the quarantined vaping products. A survey was issued on July 2, 2020 to obtain public comment from government, industry, scientific, and public health stakeholders, among other constituents, including patients and consumers, to help identify the root cause of the heavy metal contamination, the health effects of elevated lead levels, and whether heavy metal content within vaporizer products could become more prominent without use over time or post-use. The survey closed on July 14, 2020 and public comments are currently available on the Commission’s website under MassCannabisControl.Com/Documents.

The Commission continues to research and evaluate information relative to vaporizer device product manufacturing processes and safety standards in furtherance of its obligation to ensure a safely regulated industry.

Washington Liquor and Cannabis Board Issues Emergency License Suspension For Smoking Exodus in Port Orchard

WASHINGTON: The Washington State Liquor and Cannabis Board (WSLCB) Friday issued an emergency suspension for Smoking Exodus, a vapor product retailer, after an investigation found multiple violations of their state licenses and violations of state and federal drug laws. The suspension is for the licensee listed below:

Smoking Exodus:1382 SE Lund Avenue, Suite 150, Port Orchard, WA 98366

The suspension covers the licensee’s Cigarette, Tobacco, and Vapor Product Retailer license, and comes after an investigation by the WSLCB including multiple complaints and onsite visits. The violations included manufacturing vapor products without the required license, having alcohol on the premises, living in the premises, and the presence of drug paraphernalia which tested positive for methamphetamine.

The license will remain suspended for a period of 180 days, during which the WSLCB will pursue permanent revocation due to the aggravating circumstances of the case.

The WSLCB educates licensees to reach compliance and enforces Washington’s liquor, cannabis and tobacco laws and regulations. The WSLCB is mandated to ensure that licensees in Washington State follow state laws and regulations. When licensees fail to comply with state law the Board, under state authority can take action including the issuance of suspensions to ensure public health and safety.

Emergency suspensions represent an extraordinary exercise of the state’s power and the WSLCB is mandated to ensure that an emergency suspension is reasonable, justifiable and legal. This is the first Board-issued emergency suspension of 2020.

TILT Holdings’ Jupiter Research Announces Partnership With The Blinc Group

Collaboration to Include Bespoke Vape Products and Partnership on Vaporization Regulatory and Compliance Legislation

MASSACHUSETTS:  TILT Holdings Inc., a foundational technology cannabis platform comprised of assets to support brands worldwide, announced that its subsidiary Jupiter Research has partnered with The Blinc Group to offer bespoke vaporization devices to its clients as well as collaborate on industry innovations, cannabis vaping regulatory and compliance issues.

“Jupiter has always taken pride in being at the forefront of innovation,” said Mark Scatterday, interim CEO at TILT and Founder/CEO of Jupiter.  “As the market continues to grow we are excited to announce our partnership with The Blinc Group, enabling bespoke solutions for our clients and leveraging their expertise when it comes to vaporization regulatory and legal compliance legislation.”

Blinc’s Co-Founder and CEO Arnaud Dumas de Rauly is the Chairman of the International ISO committee on Vaping Standards, Chairman of the European CEN Committee on Vapor Products, former President of FIVAPE in the EU, and a renowned expert in inhalation technology, regulations, manufacturing and distribution.

“We look forward to working closely with Jupiter and bringing additional value and expertise to their extensive network of clients,” said Mr. Dumas de Rauly. “I am excited to see what the future of cannabis vaping landscape holds when two companies like Jupiter and Blinc work closely together to help shape the new standards and set an example for regulatory compliance as a whole.”

In addition to working on bespoke products together for key clients, Jupiter plans to leverage Blinc’s extensive quality control, regulatory and compliance expertise to remain at the forefront of vaporization legislation, ensuring safe and compliant consumption across the United States and internationally.

In January, the Centers for Disease Control and Prevention ended its ‘state of emergency’ general public advisory against vaping, due to the sharp decline in e-cigarette, or vaping, product use-associated lung injury cases being reported. The focus and scope of efforts to address the unregulated businesses and unlicensed storefronts is still an important factor in maintaining safety in the industry. The Blinc and Jupiter partnership represents an opportunity to accelerate and foster industry innovation and collaboration beyond vaporization.

Washington: December 1, Deadline for Marijuana Vapor Product Ingredient Disclosure Forms

WASHINGTON: WSLCB issues reminder of December 1, Deadline for Marijuana Vapor Product Ingredient Disclosure Forms.

Thank you to processors who have already submitted their vapor product ingredient disclosure forms to the LCB.

For those who have not yet submitted, please note that the deadline for all processor licensees to submit the vapor product ingredient disclosure forms to the LCB is December 1, 2019. The emergency rules filed Oct. 16, 2019 require cannabis processors to disclose all compounds, including but not limited to ingredients, solvents, additives, preservatives, thickening agents, terpenes and other substances used to produce or added to marijuana concentrates for inhalation or marijuana-infused extracts for inhalation at any point during production and processing, regardless of source and origin. All processors, regardless of whether or not they produce vapor products, must return the form.

  • The disclosure form can be found here. Please follow the instructions within the document and submit to mjdisclosureform@lcb.wa.gov.
  • For tips and answers to frequently asked questions about the disclosure form click here.

OLCC Affirms Authority To Prohibit Marijuana Adulterants, Ban Vitamin E Acetate From Marijuana Vapes

OLCC logo

OREGON: At its monthly meeting on November 21, 2019, the Commissioners of the Oregon Liquor Control Commission affirmed the OLCC’s existing authority to ban adulterants, such as Vitamin E acetate, from inclusion in marijuana products.  The Commission also approved eight marijuana violation stipulated settlement agreements.

Public health investigators with the US Centers for Disease Control (CDC) have identified Vitamin E acetate as a potential culprit in the national vaping respiratory illness outbreak.  Forty-two people, including two in Oregon, have died from the illness.  More than 2,100 individuals have been afflicted with the lung injury, including 18 Oregonians.

Previously the OLCC had not expressly allowed or banned Vitamin E acetate from being mixed into marijuana vaping products.  Ingredients for marijuana products are already screened as part of the OLCC’s packaging and labeling pre-approval process.  The Commission’s action supports both the public health finding and the agency’s ability to ban Vitamin E acetate.

“We’re making it clear that to protect consumer health we will vigorously scrutinize what goes into marijuana products sold in Oregon’s legal marketplace,” said Steve Marks, OLCC Executive Director.  “The Commission is taking steps with our regulatory partners to put in place additional consumer safeguards.  Just this week we discussed with the legislature establishing a state-run reference lab so that regulators can test marijuana products in an effort to better protect consumers.”

Under Oregon law, the OLCC can prohibit recreational marijuana licensees from selling a marijuana item that contains “injurious or adulterated” ingredients. See ORS 475B.232(2) for reference.

Under existing OLCC administrative rules “adulterated” is defined to mean in part “a foreign, inferior, poisonous or deleterious ingredient or substance that renders the marijuana item injurious to health.  See OAR 845-025-1015(2) for reference.  Based upon the CDC finding, the OLCC has determined that Vitamin E acetate is an adulterant.

Vitamin E acetate may continue to be included in non-inhaled marijuana products, such as lotions and edibles, so long as its introduction into those products meets all other OLCC requirements.

The Commission approved the following fines and/or marijuana license suspensions, license surrenders, or marijuana worker permit surrender based on stipulated settlements:

Deshe’ in Gladstone will pay a fine of $4,950 and serve a 15-day marijuana retailer license suspension or serve a 45-day license suspension for one violation.

Licensees are: Emily Lumachi, President/Director/Stockholder; Jeremy Lumachi, Secretary/Director /Stockholder; Shane Hutchins, Director/Stockholder; Alan Hutchins, Director/Stockholder.

Decibel Farms* will pay a fine of $1,485 or serve a nine-day marijuana producer license suspension for one violation.

Licensees are: Decibel Farms, Inc.; Shawn Bishop, President; Horace Wilson, Secretary

4-Twenty Market in Eugene will surrender its recreational marijuana retailer license for two violations and the licensee will receive a letter of reprimand.

Licensee is: Seed Soil Sun, LLC; Kevin Blum, Member.

Gold River Botanicals in Rogue River will pay a fine of $6,600 or serve a 40-day marijuana retailer license suspension for two violations.

Licensees are: Gold River Botanicals, LLC; Richard Porta, Member; Norma Porta, Member

Top Hill Cannabis* will pay a fine of $6,105 or serve a 37-day marijuana producer license suspension for five violations.

Licensees are: Top Hill Cannabis, LLC; Loni Schaffer, Member; Robert Schaffer, Member

Sweet Leaf Cannabis in Eugene will surrender its recreational marijuana retailer license for six violations and the licensee will receive a letter of reprimand.

Licensee is: Sweet Leaf Cannabis of Eugene, LLC; Jeremy Wheeler, Member

Sweet Leaf Cannabis in Springfield will surrender its recreational marijuana retailer license for seven violations and the licensee will receive a letter of reprimand.

Licensee is: Sweet Leaf Cannabis LLC; Jeremy Wheeler, Member

Heavy Lids will surrender its recreational marijuana producer license for nine violations and the licensee will receive a letter of reprimand.

Licensee is: Heavy Lids, LLC; Jeremy Wheeler, Member